Ultralytics FastSAM up to b4ed20c2fed75eadc5aa7d8b09fedd137b873b52 AutoBackend Model Loading autobackend.py session.get_modelmeta.custom_metadata_map imgsz/names/kpt_shape eval injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.3 | $0-$5k | 2.32 |
Summary
A vulnerability categorized as problematic has been discovered in Ultralytics FastSAM up to b4ed20c2fed75eadc5aa7d8b09fedd137b873b52. This vulnerability affects the function session.get_modelmeta.custom_metadata_map of the file ultralytics/nn/autobackend.py of the component AutoBackend Model Loading. Such manipulation of the argument imgsz/names/kpt_shape leads to eval injection.
This vulnerability is traded as CVE-2026-111237. An attack has to be approached locally. There is no exploit available.
This product operates on a rolling release basis, ensuring continuous delivery. Consequently, there are no version details for either affected or updated releases.
The project was informed of the problem early through an issue report but has not responded yet.
Details
A vulnerability was found in Ultralytics FastSAM up to b4ed20c2fed75eadc5aa7d8b09fedd137b873b52 and classified as problematic. Affected by this issue is the function session.get_modelmeta.custom_metadata_map of the file ultralytics/nn/autobackend.py of the component AutoBackend Model Loading. The manipulation of the argument imgsz/names/kpt_shape with an unknown input leads to a eval injection vulnerability. Using CWE to declare the problem leads to CWE-95. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes code syntax before using the input in a dynamic evaluation call (e.g. "eval"). Impacted is confidentiality, integrity, and availability.
The advisory is shared for download at github.com. This vulnerability is handled as CVE-2026-111237. The exploitation is known to be easy. The attack needs to be approached locally. There are known technical details, but no exploit is available.
The project was informed of the problem early through an issue report but has not responded yet.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.3VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.3
VulDB Temp Score: 5.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Eval injectionCWE: CWE-95 / CWE-94 / CWE-74
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: No
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
10/15/2026 Advisory disclosed10/15/2026 VulDB entry created
10/15/2026 VulDB entry last update
Sources
Advisory: 288Status: Confirmed
CVE: CVE-2026-111237 (🔒)
GCVE (CVE): GCVE-0-2026-111237
GCVE (VulDB): GCVE-100-420764
Entry
Created: 10/15/2026 20:30Changes: 10/15/2026 20:30 (58)
Complete: 🔍
Submitter: Dem00000
Cache ID: 216::103
Submit
Accepted
- Submit #1004882: CASIA-LMC-Lab FastSAM up to main commit b4ed20c2fed75eadc5aa7d8b09fedd137b873b52 (vendors ultralytics 8.0.120) Code Injection (by Dem00000)
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.